Claritin, Loratadine Newswire (Page 3)

Comprehensive Real-Time News Feed for Claritin, Loratadine (generic). (Page 3)

Results 41 - 60 of 297 in Claritin, Loratadine (generic)

  1. In Brief: Office Depot plans to close at least 400 U.S. storesRead the original story

    May 6, 2014 | Erie Times News

    Office Depot is planning to close at least 400 U.S. stores, as its merger with OfficeMax resulted in an overlap of retail locations that can be consolidated.

    Comment?

  2. Bayer of a deal: Merck selling its OTC businessRead the original story

    May 6, 2014 | Daily Record

    Germany's Bayer plans to buy Merck & Co.' s consumer health business, creating a combined medicine cabinet of household names from Bayer's aspirin to Merck's Claritin allergy pills.

    Comment?

  3. Merck: New drugs pending approval or in late testsRead the original story

    May 6, 2014 | Silver City Sun-News

    Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.

    Comment?

  4. US stocks dragged lower by weakness at Twitter, AIGRead the original story

    May 6, 2014 | Channelnewsasia.com

    US stocks retreated on Tuesday as a sell-off in Twitter revived worries about the tech sector and disappointing earnings from insurer AIG hit financial stocks.

    Comment?

  5. Stocks fall in early trading before Yellen talkRead the original story

    May 6, 2014 | ETaiwanNews.com

    U.S. stocks are falling in early trading on Tuesday as corporate earnings wind down and investors wait for testimony from Federal Reserve Chair Janet Yellen on the economy.

    Comment?

  6. Stocks end sharply lower; Dow drops 130Read the original story

    May 5, 2014 | USA Today

    The Dow finished down 0.8% to 16,401.02. The Standard & Poor's 500 index dropped 0.9% to 1,867.72 and the Nasdaq composite index lost 1.4%, ending at 4,080.76.

    Comment?

  7. Stock futures slipping before Yellen testimony about 4 hoursRead the original story

    May 6, 2014 | The Review

    U.S. stock futures are trading lower as investors await comments from Federal Reserve Chair Janet Yellen, scheduled to address Congress on the economy.

    Comment?

  8. Merck CEO Says He Probably Won't Sell Animal Health BusinessRead the original story

    May 6, 2014 | Forbes.com

    But in some ways, it's more of an M&A day, because Merck announced in the morning that it had sold its consumer health division, the maker of household brands like Claritin allergy medicine, Coppertone sunscreen, and Dr. Scholl's foot products for $14.2 billion in cash.

    Comment?

  9. Merck sells over-the-counter business to Bayer for $14.2BRead the original story

    May 6, 2014 | Business Journal

    Bloomberg's Scarlet Fu reports that Bayer has agreed to acquire Merck's consumer products unit in a deal worth $14.2 billion on Bloomberg Television's "Bloomberg Surveillance."

    Comment?

  10. Allergy Medications: Which Drugs Treat Which SymptomsRead the original story

    May 2, 2014 | LiveScience

    When spring is in the air, as the millions of people who suffer from seasonal allergies know, so are pollen, mold and other microscopic annoyances.

    Comment?

  11. Ranbaxy Recalls Nearly 30,000 Packs of Allergy-relief Drug in U.SRead the original story w/Photo

    May 2, 2014 | International Business Times

    The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy's Ohm Labs plant in , have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of ... (more)

    Comment?

  12. Thousands of allergy pills recalledRead the original story w/Photo

    May 2, 2014 | KUQL-FM Mitchell

    Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

    Comment?

  13. Generic Anti-Allergy Drugs RecalledRead the original story

    May 2, 2014 | Drugs.com

    FRIDAY May 2, 2014, 2014 -- Nearly 30,000 packets of generic anti-allergy medicines are being recalled in the United States by Indian drug maker Ranbaxy Laboratories Ltd. The recalled allergy relief and nasal decongestant products were made by Ranbaxy's U.S. subsidiary Ohm Laboratories Inc., the Wall Street Journal reported.

    Comment?

  14. Health Highlights: May 2, 2014Read the original story

    May 2, 2014 | HON

    The United States is one of the few countries worldwide that had an increase in pregnancy- and childbirth-related deaths in the past decade, a new study says.

    Comment?

  15. Ranbaxy Recalls Nearly 30,000 Packs Of Allergy-Relief Drug In U.S.Read the original story

    May 2, 2014 | Lincoln Daily News

    Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

    Comment?

  16. Ranbaxy, Indian Drugmaker, Recalls Nearly 30,000 Packs Of Allergy...Read the original story w/Photo

    May 2, 2014 | Medical Daily

    Indian drugmaker Ranbaxy Laboratories Ltd. has recalled 30,000 packs of generic allergy-relief medication from its U.S. stores, following the Food and Drug Administration finding defects in the products' packaging.

    Comment?

  17. Bayer Said to Be in Exclusive Talks for Merck Consumer UnitRead the original story

    May 1, 2014 | The Washington Post

    Bayer AG is in exclusive talks to acquire Merck & Co.' s consumer business and is prepared to pay about $14 billion for the division, people with knowledge of the matter said.

    Comment?

  18. Harsh Winter Followed by Brutal Allergy SeasonRead the original story w/Photo

    May 1, 2014 | WAND-TV Decatur

    Many in Central Illinois are finding this to be one of the worst allergy seasons in recent memory.

    Comment?

  19. Coppertone to Bayer?Read the original story

    May 1, 2014 | HAPPI/Household & PP Industry

    German drugmaker Bayer AG is nearing an agreement to buy Merck & Co Inc's consumer healthcare unit, people familiar with the matter said, in a deal that could value the business at around $14 billion.

    Comment?

  20. Bayer nears deal to buy Merck consumer unit -sourcesRead the original story

    May 1, 2014 | Reuters

    German drugmaker Bayer AG is nearing an agreement to buy Merck & Co Inc's consumer healthcare unit, people familiar with the matter said, in a deal that could value the business at around $14 billion.

    Comment?